Edward Silberstein

Edward B Silberstein , MD

University of Cincinnati Medical Center
PO Box 670761
Cincinnati, Ohio 46276-0761
Phone 513-558-2043
Fax 513-558-1599
Email silbereb@ucmail.uc.edu

Education

Bachelor's Degree: Yale University New Haven, CT , 1958 (Zoologic Science)

Medical Degree: Harvard Medical School Boston, MA, 1962

Internship: Cincinnati General Hospital Cincinnati, OH, 1963

Residency: Cincinnati General Hospital Cincinnati, OH, 1964

Residency : Dewitt Army Hospital - Walter Reed Hospital Bethesda, MD, 1966

Residency : University Hospital Cleveland Cleveland, OH , 1967 (Internal Medicine )

Fellowship: National Institute of Health Boston, MA , 1968

Master's Degree: University of Cincinnati Cincinnati, OH, 2008 (Art History)

Certifications

American Board of Internal Medicine (Hematology) (Certification Date: 10-17-1972 )

American Board of Internal Medicine (Certification Date: 10-21-1969 ) - (Recertification Date: to 10-25-1980 )

American Board of Internal Medicine (Medical Oncology) (Certification Date: 11-10-1981 )

American Board of Nuclear Medicine (Certification Date: 03-25-1972 )

Clinical Interests

Hematology

Medical Oncology

Nuclear Medicine

Radiology

Research and Practice Interests

Hematoloy Oncology

Positions and Work Experience

1977 -To Present Professor of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH

1983 -To Present Professor of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

2001 -To Present Professor Emeritus of Radiology and Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

1968 -To Present Attending Physician in Medicine and Radiology and Clinician in Radiology and Medicine, University Hospital, Cincinnati, OH

Publications

Published Abstracts

Abstracts since 2000 only - latest 5 of 79 .[Abstract]

Gass M, Silberstein EB, Fernandez M, et all (07-2000. ) Comparison of three peripheral bone density machines to contral DXA .[Abstract]

Rios JA, Pratt P, Silberstein EB, et al (2000. ) A study of normal subjects with unexpectedly low 24-H51Cr recovery of red blood cells .[Abstract]Transfusion, 40 ,1295 (SP 356)

Silberstein EB (2001. ) A randomized study of the value of dosimetry in the use of iodine-131 for ablation of post-operative thyroid remnants .[Abstract]J Nucl Med, 42 ,350P

Silberstein EB (2004. ) A comparison of I-131 ablative therapy results after diagnostic scans with I-123 or I-131 for thyroid CA: A stunning result .[Abstract]J Nucl Med, 45 ,289-290P

Silberstein EB (2007. ) Prevention of radiation-induced sialadenitis and glossitis after I-131 therapy for thyroid cancer .[Abstract]J Nucl Med, 47 ,14P

Peer Reviewed Publications

Silberstein EB et al (2008. ) Society of Nuclear Medicine Procedure Guideline for Therapy of Thyroid Disease with Iodine-131 .J Nucl Med Technol, ,

Silbertsein EB (2008. ) Reducing the incidence of iodine-131-induced sialadenitis: The role of pilocarpine .J Nucl Med, , 49 ,546-549

Silbertstein EB (2008. ) Eugene Lange Saenger .J Nucl Med, , 49 ,20-21

Siegel J, Silberstein EB (2008. ) A closer look at the latest NRC Patient Release Guidance .J Nucl Med, , 49 ,17N-20N

Janjan N, Lutz S, Bedwinek JM, Hartsell WF, Silberstein EB et al (2009. ) A report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology: Clinical trials and socioeconomic implications in the treatment of bone metastases .J Palliative Care, , 12 ,427-431

Janjan N, Lutz S, Bedwinek JM, Hartsell WF, Silberstein EB et al (2009. ) A report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology: Clinical trails and socioeconomic implications in the treatment of bone metastasies .J Palliative Care, , 12 ,417-426

Siegel, Jeffry A; Silberstein, Edward B (2014. ) The AEC/NRC 30 mCi rule: regulatory origins and clinical consequences for 131I remnant ablative doses.Thyroid : official journal of the American Thyroid Association, , 24 (11 ) ,1625-35 More Information

Silberstein, Edward B (2014. ) Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , 55 (8 ) ,1308-1310 More Information

Siegel JA, Greenspan BS, Maurer AH, Taylor AT, Phillips WT, Van Nostrand D, Sacks B, Silberstein EB (2018. ) The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment.J Nucl Med, , 59 (7 ) ,1017 More Information

Silberstein EB (2017. ) Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur!.J Nucl Med, , 58 (8 ) ,1356 More Information

Siegel JA, Greenspan B, Silberstein EB, Sacks B, Marcus CS, Stabin MG (2018. ) Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise.J Nucl Med, , 59 (10 ) ,1489 More Information

Gugliucci, Marilyn R; Padmanabhan, Divya L; Silberstein, Emily B (2020. ) 48-Hour Hospice Home Immersion Encourages Osteopathic Medical Students to Broaden Their Views on Dying and Death.The Journal of the American Osteopathic Association, , 120 (8 ) ,516-523 More Information

Greenspan, Bennett S; Siegel, Jeffry A; Hassan, Aamna; Silberstein, Edward B (2019. ) There Is No Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , 60 (11 ) ,1500-1501 More Information

Siegel, Jeffry A; Brooks, Antone L; Fisher, Darrell R; Zanzonico, Pat B; Doss, Mohan; O?Connor, Michael K; Silberstein, Edward B; Welsh, James S; Greenspan, Bennett S (2019. ) A Critical Assessment of the Linear No-Threshold Hypothesis: Its Validity and Applicability for Use in Risk Assessment and Radiation Protection.Clinical nuclear medicine, , 44 (7 ) ,521-525 More Information

Siegel, Jeffry A; Greenspan, Bennett; Silberstein, Edward B; Sacks, Bill; Marcus, Carol S; Stabin, Michael G (2018. ) Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , 59 (10 ) ,1489-1490 More Information

Siegel, Jeffry A; Greenspan, Bennett S; Maurer, Alan H; Taylor, Andrew T; Phillips, William T; Van Nostrand, Douglas; Sacks, Bill; Silberstein, Edward B (2018. ) The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , 59 (7 ) ,1017-1019 More Information

Silberstein, Edward B (2017. ) Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur!.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , 58 (8 ) ,1356 More Information

Published Books

Silberstein EB (1983. ) Bone Scintigraphy .Mt. Kisco, NY , Futura Corporation

Silberstein EB (1987. ) New Directions in Nuclear Medicine - Preparing for the Future .Southeastern Chapter, Society of Nuclear Medicine (Editor)

Silberstein EB, McAfee J, Spasoff A (1998. ) Diagnostic Patterns .Reston, VA , Society of Nuclear Medicine (Co-Author)

Silberstein EB, McAfee J (1983. ) Differential Diagnosis .New York, NY , McGraw-Hill (Co-Author)

St. Germain J, Silberstein EB, Vetter RJ, et al (12-11-2006. ) NCRP Report No. 155. Management of Radionuclide Therapy Patients: Recommendations of the National Council on Radiation Protection and Management .Washington, DC , National Council on Radiation Protection and Management (Co-Author)

Book Chapter

Book Chapters since 2000 only - 7 of 49

Silberstein EB (2000 ) Bone Cancer Therapy Self-Study Program IV: Unit 5 .(pp. 2-36)).Society of Nuclear Medicine

Silberstein EB (2002 ) Treatment of pain from bone metastasis employing unsealed sources Diagnostic Nuclear Medicine .(pp. 1027-1035)).Lippincott & Williams & Wilkins

Silberstein EB (2006 ) Adverse reactions to radiopharmaceutical agents and long term effects Nuclear Medicine .(pp. 498-506)).Chicago, IL, Mosby-Elsevier

Silberstein EB (2006 ) Treatment of thyroid malignant neoplasms Nuclear Medicine .(pp. 1576-1587)).Chicago, IL, Mosby-Elsevier

Silberstein EB (2006 ) Skeletal scintigraphy in non-neoplastic osseous disorders Nuclear Medicine .(pp. 988-993)).Chicago, IL, Mosby-Elsevier

Silbestein EB (2007 ) Nuclear hematology Clinical Nuclear Medicine .(pp. 307-321)).New York, NY, Springer-Verlag

Silberstein EB (2007 ) Palliation of bone pain from osteoblastic metastasis Nuclear Medicine Therapy .(pp. 77-101)).Informa Healthcare USA

Keywords

Nuclear Medicine, Radiobiology, Radiation effects, Diseases(MeSH C),Analytical, Diagnostic and Therapeutic Techniques and Equipment(MeSH E), Neoplasms(MeSH C04), Hemic and Lymphatic Diseases(MeSH C15),Endocrine Diseases(MeSH C19), Diagnosis(MeSH E01), Therapeutics(MeSH E02)

Professional Affiliation

2005 -To Present: Consultant Cancer Research UK

1974 -To Present: Outside Reviewer Journal of Nuclear Medicine

2001 -To Present: United States Pharmacopeia, Radiopharmaceuticals Information Expert Committee

1995 -To Present: Advisory Committee and Consultant Food and Drug Administration Center for Devices and Radiological Health Medical Reaction Advisory Committee and Consultant on Adverse Reactions

1980 -To Present: Consultant Nuclear Regulatory Commission Consultant on Radiation Accidents

1998 -To Present: Consultant National Institute of Occupational Safety and Health

Contact Information

Academic - University of Cincinnati Medical Center
PO Box 670761
CincinnatiĀ  Ohio, 46276-0761
Phone: 513-558-2043
Fax: 513-558-1599
silbereb@ucmail.uc.edu